Oxygenation of advanced head and neck cancer: Prognostic marker for the response to primary radiochemotherapy

被引:24
|
作者
Vanselow, B
Eble, MJ
Rudat, V
Wollensack, P
Conradt, C
Dietz, A
机构
[1] Heidelberg Univ, Dept Otolaryngol Head & Neck Surg, D-6900 Heidelberg, Germany
[2] Heidelberg Univ, Dept Radiat Oncol, D-6900 Heidelberg, Germany
[3] Heidelberg Univ, Inst Med Biometry, D-6900 Heidelberg, Germany
关键词
D O I
10.1016/S0194-5998(00)70014-3
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Recent clinical studies suggest that the degree of tumor oxygenation may be predictive of the response of radiation therapy for cancer. In an exploratory investigation of cervical lymph node metastases in 27 patients with advanced squamous cell carcinoma of the oropharynx and hypopharynx, this relationship was investigated by means of oxygen measurements with an Eppendorf PO2 histograph, The measurements were made before the start of radiation therapy and after the first week of therapy. Clinical response was evaluated 6 weeks after the completion of therapy. Before therapy, marked hypoxia was observed in the lymph node metastases, with a mean PO:! value of 16.1 +/- 8.2 mm Hg and a hypoxic fraction (Po-2 < 10 mm Hg) of 56.4% +/- 20.0%. After the first week of radiation (9 Gy) there was a general reoxygenation (Delta Po-2 = 5.0 +/- 10.1 mm Hg, P < 0.05; Delta hypoxic fraction = -11.3% +/- 31.3%, P = 0.11), A relationship between the degree of reoxygenation and tumor response was not observed, Patients without at least partial lymph node response (n = 8) showed poorer pretherapeutic oxygenation (Po-2 mean = 11.1 +/- 2.9 mm Hg) than those who responded to the therapy (n = 19, P(o)2 mean = 18.2 +/- 8.8 mm Hg). In this investigation of a defined set of patients with advanced carcinoma of the oropharynx and hypopharynx, we found that pretherapeutic oxygenation data are predictive for the therapeutic response to radiation therapy or radiochemotherapy.
引用
收藏
页码:856 / 862
页数:7
相关论文
共 50 条
  • [1] Prognostic factors in primary radiochemotherapy of advanced head and neck tumours with specific reference to the tumour cell cycle components and tumour oxygenation
    Dietz, A
    LARYNGO-RHINO-OTOLOGIE, 2002, 81 (01): : 63 - 64
  • [2] "Neck dissection" of the residually positive neck after primary radiochemotherapy for locally advanced head and neck cancer
    Christiansen, H.
    Roedel, R. M. W.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2012, 188 (05) : 444 - 445
  • [3] Prognostic factors in patients with locally advanced head and neck cancer treated with concurrent radiochemotherapy
    Franceschini, Davide
    Paiar, Fabiola
    Saieva, Calogero
    Bonomo, Pierluigi
    Agresti, Benedetta
    Meattini, Icro
    Greto, Daniela
    Mangoni, Monica
    Meacci, Fiammetta
    Loi, Mauro
    Zei, Giacomo
    Livi, Lorenzo
    Biti, Giampaolo
    RADIOLOGIA MEDICA, 2016, 121 (03): : 229 - 237
  • [4] Prognostic factors in patients with locally advanced head and neck cancer treated with concurrent radiochemotherapy
    Davide Franceschini
    Fabiola Paiar
    Calogero Saieva
    Pierluigi Bonomo
    Benedetta Agresti
    Icro Meattini
    Daniela Greto
    Monica Mangoni
    Fiammetta Meacci
    Mauro Loi
    Giacomo Zei
    Lorenzo Livi
    Giampaolo Biti
    La radiologia medica, 2016, 121 : 229 - 237
  • [5] Amifostine in simultaneous radiochemotherapy of advanced head and neck cancer
    Büntzel, J
    Glatzel, M
    Kuttner, K
    Weinaug, R
    Fröhlich, D
    SEMINARS IN RADIATION ONCOLOGY, 2002, 12 (01) : 4 - 13
  • [6] Radiochemotherapy as the standard of care for advanced head and neck cancer
    Semrau, R.
    Fietkau, R.
    Werner, J. A.
    Mueller, R. -P.
    ONKOLOGE, 2007, 13 (02): : 165 - 173
  • [7] Prognostic significance of cell-cycle regulatory proteins for outcome after primary radiochemotherapy in patients with advanced head and neck cancer
    Haas, S
    Bosch, FX
    Klein-Kühne, W
    Nollert, J
    Rudat, V
    Conradt, C
    Dietz, A
    HNO, 1999, 47 (09) : 777 - +
  • [8] Neck dissection after radiochemotherapy in patients with locoregionally advanced head and neck cancer
    Mario López Rodríguez
    Laura Cerezo Padellano
    Margarita Martín Martín
    Felipe Couñago Lorenzo
    Clinical and Translational Oncology, 2008, 10
  • [9] Planned neck dissection after concomitant radiochemotherapy for advanced head and neck cancer
    Frank, DK
    Hu, KS
    Culliney, BE
    Persky, MS
    Nussbaum, M
    Schantz, SP
    Malamud, SC
    Holliday, RA
    Khorsandi, AS
    Sessions, RB
    Harrison, LB
    LARYNGOSCOPE, 2005, 115 (06): : 1015 - 1020
  • [10] Radiochemotherapy in head and neck cancer
    Merlano, M
    Marchetti, G
    CANCER TREATMENT REVIEWS, 2003, 29 (04) : 291 - 296